Aptamer Group PLC

Company Profile

Sector

Healthcare

Industry

Biotechnology

Employees

30

Website

aptamergroup.com

Country

🇬🇧 United Kingdom

Exchange

LSE

Founded 2008York

Aptamer provides synthetic binders for research, diagnostics, and therapeutics globally. The company offers Optimer, a platform that enables the discovery and development of optimized DNA and RNA aptamers, which can bind to target molecules. Its platform is used in research reagent and analytical, bioprocessing, diagnostic, cosmetic and consumer health, and therapeutic applications.

The company serves pharmaceutical, diagnostic, and bioprocessing companies. It has collaborations with Unilever, Neuro-Bio, the University of Glasgow, AstraZeneca, and Invizius. Founded in 2008, Aptamer is headquartered in York, the United Kingdom.

Key Stats

52-Week Range

£0.00£1.57

Beta0.90

Trailing P/EN/A

Forward P/EN/A

Trailing EPS0.00

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceN/A

RecommendationNone

Recommendation MeanN/A

Recent SEC Filings

SEC filings for this ticker are not available yet.